These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8572388)

  • 1. [Muromonab CD3 (Orthoclone OKT3) for the prophylaxis of heart allograft rejection. Hemodynamics and respiratory tolerance].
    Guinvarc'h A; Fouillard A; Amrein C; Guillemain R; Chevalier P; Acar C; Couetil JP; Vulser C
    Ann Fr Anesth Reanim; 1995; 14(4):331-5. PubMed ID: 8572388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muromonab CD3: a reappraisal of its pharmacology and use as prophylaxis of solid organ transplant rejection.
    Wilde MI; Goa KL
    Drugs; 1996 May; 51(5):865-94. PubMed ID: 8861551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hemodynamic effects of intraoperative injection of muromonab CD3.
    Robinson ST; Barry JM; Norman DJ
    Transplantation; 1993 Aug; 56(2):356-8. PubMed ID: 8356590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction immunosuppression for lung transplantation with OKT3.
    Wain JC; Wright CD; Ryan DP; Zorb SL; Mathisen DJ; Ginns LC
    Ann Thorac Surg; 1999 Jan; 67(1):187-93. PubMed ID: 10086547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective randomized study of prophylactic OKT3 versus equine antithymocyte globulin after heart transplantation--increased morbidity with OKT3.
    Macdonald PS; Mundy J; Keogh AM; Chang VP; Spratt PM
    Transplantation; 1993 Jan; 55(1):110-6. PubMed ID: 8380508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical experience with Muromonab-CD3 monoclonal antibody (OKT3) in heart transplantation.
    Macris MP; Frazier OH; Lammermeier D; Radovancevic B; Duncan JM
    J Heart Transplant; 1989; 8(4):281-7. PubMed ID: 2504894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OKT3 monoclonal antibody given for ten versus fourteen days as immunosuppressive prophylaxis in heart transplantation.
    Hegewald MG; O'Connell JB; Renlund DG; Lee HR; Burton NA; Karwande SV; Jones KW; Lassetter JE; Bristow MR
    J Heart Transplant; 1989; 8(4):303-9; discussion 309-10. PubMed ID: 2504897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OKT3 prophylaxis versus conventional drug therapy: single-center perspective, part of a multicenter trial.
    Kahana L; Narvarte J; Ackermann J; LeFor W; Weinstein S; Wright C; deQuesada A; Baxter J; Shires D
    Am J Kidney Dis; 1989 Nov; 14(5 Suppl 2):5-9. PubMed ID: 2510510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ten years of Orthoclone OKT3 (muromonab-CD3): a review.
    Smith SL
    J Transpl Coord; 1996 Sep; 6(3):109-19; quiz 120-1. PubMed ID: 9188368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized multicenter comparison of basiliximab and muromonab (OKT3) in heart transplantation: SIMCOR study.
    Segovia J; Rodríguez-Lambert JL; Crespo-Leiro MG; Almenar L; Roig E; Gómez-Sánchez MA; Lage E; Manito N; Alonso-Pulpón L
    Transplantation; 2006 Jun; 81(11):1542-8. PubMed ID: 16770243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective, randomized comparison of cyclophosphamide and azathioprine for early rejection prophylaxis after cardiac transplantation. Decreased sensitization to OKT3.
    Taylor DO; Bristow MR; O'Connell JB; Ensley RD; Olsen SL; Hammond EH; Wagoner LE; Renlund DG
    Transplantation; 1994 Sep; 58(6):645-9. PubMed ID: 7940682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cardiopulmonary response to OKT3 in orthotopic cardiac transplant recipients.
    Stein KL; Ladowski J; Kormos R; Armitage J
    Chest; 1989 Apr; 95(4):817-21. PubMed ID: 2494022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muromonab-CD3 (Orthoclone OKT3), methylprednisolone and cyclosporine for acute graft-versus-host disease prophylaxis in allogeneic bone marrow transplantation.
    Benekli M; Hahn T; Williams BT; Cooper M; Roy HN; Wallace P; Stewart C; Bambach B; McCarthy PL
    Bone Marrow Transplant; 2006 Sep; 38(5):365-70. PubMed ID: 16862164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of renal allograft rejection with T10B9.1A31 or OKT3: final analysis of a phase II clinical trial.
    Waid TH; Lucas BA; Thompson JS; McKeown JW; Brown S; Kryscio R; Skeeters LJ
    Transplantation; 1997 Jul; 64(2):274-81. PubMed ID: 9256187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic therapy for rejection after cardiac transplantation. A comparison of rabbit antithymocyte globulin and OKT3.
    Kirklin JK; Bourge RC; White-Williams C; Naftel DC; Thomas FT; Thomas JM; Phillips MG
    J Thorac Cardiovasc Surg; 1990 Apr; 99(4):716-24. PubMed ID: 2108282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. OKT3 salvage therapy in a quadruple immunosuppressive protocol in cadaveric renal transplantation.
    D'Alessandro AM; Pirsch JD; Stratta RJ; Sollinger HW; Kalayoglu M; Maki DG; Belzer FO
    Transplantation; 1989 Feb; 47(2):297-300. PubMed ID: 2493176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting factors of long-term results of OKT3 therapy for steroid resistant acute rejection following cadaveric renal transplantation.
    Rostaing L; Chabannier MH; Modesto A; Rouzaud A; Cisterne JM; Tkaczuk J; Durand D
    Am J Nephrol; 1999; 19(6):634-40. PubMed ID: 10592356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular collapse following orthoclone OKT3 administration: a case report.
    Lee CW; Logan JL; Zukoski CF
    Am J Kidney Dis; 1991 Jan; 17(1):73-5. PubMed ID: 1898835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction therapy with OKT3 in pediatric liver-transplant recipients.
    Ryckman FC; Schroeder TJ; Pedersen SH; Dittrich VS; Balistreri WF
    Transplant Sci; 1994 Dec; 4 Suppl 1():S20-5. PubMed ID: 7627451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized clinical trial of induction therapy with OKT3 in kidney transplantation.
    Norman DJ; Kahana L; Stuart FP; Thistlethwaite JR; Shield CF; Monaco A; Dehlinger J; Wu SC; Van Horn A; Haverty TP
    Transplantation; 1993 Jan; 55(1):44-50. PubMed ID: 8420063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.